SPONSOR
Nanjing Leads Biolabs Co.,Ltd
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Relapsed/Refractory Multiple MyelomaTriple Negative Breast CancerAdvanced Solid Tumour
NCT06049290 Phase 1, Phase 2
Recruiting
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
NCT07281976 Phase 1, Phase 2
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Triple Negative Breast Cancer
NCT07111546 Phase 2
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Advanced Solid Tumour